132 related articles for article (PubMed ID: 33054029)
1. [Retroperitoneal dedifferentiated liposarcomas: semi-quantitative assessment of the dedifferentiated component and prognosis].
Volkov AY; Kozlov NA; Nered SN; Stilidi IS; Stroganova AM; Arkhiri PP; Antonova EY; Privezentsev SA
Arkh Patol; 2020; 82(5):25-32. PubMed ID: 33054029
[TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and histopathological review of dedifferentiated liposarcoma: a comprehensive study of 123 primary tumours.
Mori T; Yamada Y; Kinoshita I; Kohashi K; Yamamoto H; Ito Y; Susuki Y; Kawaguchi K; Nakashima Y; Oda Y
Histopathology; 2022 Feb; 80(3):538-557. PubMed ID: 34699612
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience.
Masaki N; Onozawa M; Inoue T; Kurobe M; Kawai K; Miyazaki J
Asian J Surg; 2021 Jan; 44(1):380-385. PubMed ID: 33191070
[TBL] [Abstract][Full Text] [Related]
5. Comparison between retroperitoneal leiomyosarcoma and dedifferentiated liposarcoma.
Ishii T; Kohashi K; Ootsuka H; Iura K; Maekawa A; Yamada Y; Bekki H; Yoshimoto M; Yamamoto H; Iwamoto Y; Oda Y
Pathol Res Pract; 2017 Jun; 213(6):634-638. PubMed ID: 28552535
[TBL] [Abstract][Full Text] [Related]
6. Retroperitoneal Dedifferentiated Liposarcoma.
Dehner CA; Hagemann IS; Chrisinger JSA
Am J Clin Pathol; 2021 Oct; 156(5):920-925. PubMed ID: 34125170
[TBL] [Abstract][Full Text] [Related]
7. Gene Expression Changes Associated with Dedifferentiation in Liposarcoma Predict Overall Survival.
Shannon NB; Tan QX; Tan JW; Hendrikson J; Ng WH; Ng G; Liu Y; Tan GHC; Wong JSM; Soo KC; Teo MCC; Chia CS; Ong CJ
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34207401
[TBL] [Abstract][Full Text] [Related]
8. Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.
Ishii T; Kohashi K; Iura K; Maekawa A; Bekki H; Yamada Y; Yamamoto H; Nabeshima K; Kawashima H; Iwamoto Y; Oda Y
Tumour Biol; 2016 Apr; 37(4):4767-76. PubMed ID: 26518767
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of p53, mdm2, and p21WAF1 in dedifferentiated liposarcoma: special emphasis on the distinct immunophenotype of the well-differentiated component.
Adachi T; Oda Y; Sakamoto A; Saito T; Tamiya S; Masuda K; Tsuneyoshi M
Int J Surg Pathol; 2001 Apr; 9(2):99-109. PubMed ID: 11484509
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of Imaging and Pathologic Findings of Retroperitoneal Dedifferentiated Liposarcoma].
Zhang JY; Yu XD; Song Y; Zhang HT; Chen Y; Ouyang H; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):223-228. PubMed ID: 30917460
[No Abstract] [Full Text] [Related]
11. Prediction of Recurrence-Free and Overall Survival in Retroperitoneal Well-Differentiated and Dedifferentiated Liposarcoma After Surgery.
Volkov AY; Nered SN; Kozlov NA; Stilidi IS; Arhiri PP; Antonova EY
Indian J Surg Oncol; 2024 Mar; 15(Suppl 1):112-118. PubMed ID: 38545590
[TBL] [Abstract][Full Text] [Related]
12. [Differentiated surgical approach for retroperitoneal non-organ liposarcoma].
Volkov AY; Nered SN; Kozlov NA; Stilidi IS; Arkhiri PP; Antonova EY; Privezentsev SA
Khirurgiia (Mosk); 2021; (7):36-44. PubMed ID: 34270192
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and survival of patients diagnosed with well-differentiated and dedifferentiated retroperitoneal liposarcoma.
Osuna-Soto J; Caro Cuenca T; Sanz-Zorrilla A; Torrecilla-Martínez A; Ortega Salas R; Leiva-Cepas F
Cir Esp (Engl Ed); 2022 Oct; 100(10):622-628. PubMed ID: 35753575
[TBL] [Abstract][Full Text] [Related]
14. Retroperitoneal dedifferentiated liposarcoma: Analysis of 61 cases from a large institution.
Luo P; Cai W; Yang L; Wu Z; Chen Y; Zhang R; Yan W; Shi Y; Wang C
J Cancer; 2018; 9(21):3831-3838. PubMed ID: 30410585
[No Abstract] [Full Text] [Related]
15. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability.
Crago AM; Socci ND; DeCarolis P; O'Connor R; Taylor BS; Qin LX; Antonescu CR; Singer S
Clin Cancer Res; 2012 Mar; 18(5):1334-40. PubMed ID: 22241790
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes.
Ikoma N; Torres KE; Somaiah N; Hunt KK; Cormier JN; Tseng W; Lev D; Pollock R; Wang WL; Feig B
Ann Surg Oncol; 2015 Apr; 22(4):1068-72. PubMed ID: 25354575
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of the immunohistochemical expression of perilipin 1 and adipophilin in high-grade liposarcoma.
Kawaguchi K; Kohashi K; Mori T; Yamamoto H; Iwasaki T; Kinoshita I; Susuki Y; Furukawa H; Endo M; Matsumoto Y; Nakashima Y; Oda Y
J Clin Pathol; 2023 May; ():. PubMed ID: 37258253
[TBL] [Abstract][Full Text] [Related]
19. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases.
Ricciotti RW; Baraff AJ; Jour G; Kyriss M; Wu Y; Liu Y; Li SC; Hoch B; Liu YJ
Cancer Genet; 2017 Dec; 218-219():69-80. PubMed ID: 29153098
[TBL] [Abstract][Full Text] [Related]
20. Retroperitoneal Liposarcoma: an Autopsy Case.
Eren F; Gürses MS; Inanir NT; Eren B; Vojtisek T
Maedica (Bucur); 2015 Jun; 10(2):140-142. PubMed ID: 28275407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
